Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004995160 | SCV005557173 | uncertain significance | Cardiovascular phenotype | 2024-07-27 | criteria provided, single submitter | clinical testing | The c.778T>G (p.F260V) alteration is located in exon 1 (coding exon 1) of the CHST14 gene. This alteration results from a T to G substitution at nucleotide position 778, causing the phenylalanine (F) at amino acid position 260 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |